Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

NCT04827563 · clinicaltrials.gov ↗
TERMINATED
Status
50
Enrollment
OTHER
Sponsor class

Stopped Study terminated by PI

Conditions

Interventions

Sponsor

University of Chicago